• (866) 969-3222
  • info@reveleer.com
reveleer_Inc5000_website
  • Line of Business
    • Medicare
      • Reveleer for HEDIS® Hybrid
      • Reveleer for HEDIS® Supplemental
      • Risk Adjustment - Retrospective
      • Risk Adjustment - Concurrent
    • Commercial
      • Reveleer for HEDIS® Hybrid
      • Reveleer for HEDIS® Supplemental
      • Risk Adjustment - Retrospective
      • Risk Adjustment - Concurrent
      • Risk Adjustment - RADV
    • Medicaid
      • Risk Adjustment - Retrospective
      • Reveleer for HEDIS® Hybrid
      • Reveleer for HEDIS® Supplemental
  • Solutions
    • Quality Improvement
      • NLP-Driven Overread for Quality Review
      • NLP for Prospective Review and Gap Closure
      • Reveleer for HEDIS® Hybrid
      • Reveleer for HEDIS® Supplemental
    • Risk Adjustment
      • NLP Total Capture
      • Risk Adjustment - Retrospective
      • Risk Adjustment - Concurrent
    • HHS-RADV Audit
      • Risk Adjustment - RADV
  • Blog
  • Resources
  • About Us
    • Leadership Team
    • Board of Directors
    • Careers
    • Contact Us
Contact us
Client Login
  • Blog
blog-banner.jpg

Blog | Reveleer

The Value-Based Healthcare Podcast - Episode 20: How Enterprise Analytics Are Transforming Healthcare

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

CMS Updates and HHS-RADV News

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Reveleer Announces Mark Eastwood as Chief Product Officer

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Reveleer Honored in LA Business Journal's 100 Fastest Growing Private Companies

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

The Value-Based Healthcare Podcast - Episode 19: Easier Access and Less Intimidating Healthcare

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Reveleer Achieves HITRUST CSF ® Certification for Risk Management, Compliance and Maximum Security

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Reveleer Announces New Quality Solution, Prospective Review and Gap Closure Powered by NLP

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Reveleer Expands its Healthcare Authority, Appoints New Members to Board of Directors

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

NEW: HHS RADV-IVA BY 2019 Timeline Explained

Share on Facebook Share on LinkedIn Share on Twitter Share on Email

Reveleer Recognized As One Of America’s Fastest Growing Companies by Inc. 5000

Share on Facebook Share on LinkedIn Share on Twitter Share on Email
< Previous Page Next Page >
  • Medicare
    • Reveleer for HEDIS® Hybrid
    • Reveleer for HEDIS® Supplemental
    • Risk Adjustment - Retrospective
    • Risk Adjustment - Concurrent
  • Commercial
    • Reveleer for HEDIS® Hybrid
    • Reveleer for HEDIS® Supplemental
    • Risk Adjustment - Retrospective
    • Risk Adjustment - Concurrent
    • Risk Adjustment - RADV
  • Medicaid
    • Risk Adjustment - Retrospective
    • Reveleer for HEDIS® Hybrid
    • Reveleer for HEDIS® Supplemental
  • Solutions
    • Quality Improvement
      • NLP-Driven Overread for Quality Review
      • NLP for Prospective Review and Gap Closure
      • Reveleer for HEDIS® Hybrid
      • Reveleer for HEDIS® Supplemental
    • Risk Adjustment
      • NLP Total Capture
      • Risk Adjustment - Retrospective
      • Risk Adjustment - Concurrent
    • HHS-RADV Audit
      • Risk Adjustment - RADV
  • Blog
  • Resources
  • About Us
    • Leadership Team
    • Board of Directors
    • Why Work for Us?
    • Careers
    • Privacy Policy
    • Contact Us

Connect

425 West Broadway
Suite 110
Glendale, CA
91204